does tirzepatide make your joints hurt Joint Pain and Tirzepatide: What the Evidence Shows The promise of tirzepatide: A

M., Allison, D

Choline bitartrate

Here is a direct comparison from published Phase 2 and Phase 3 data: Semaglutide (Ozempic/Wegovy): Average weight loss of 14.9% at 68 weeks in the STEP 1 trial Tirzepatide (Mounjaro): Average weight loss of 20.9% at 72 weeks in the SURMOUNT-1 trial Retatrutide: Average weight loss of 24.2% at 48 weeks in the Phase 2 trial Retatrutide reached a higher percentage of weight loss in fewer weeks

Kidney Impairment Hepaglide is usually safe for kidney patients, but it requires caution in people with Chronic Kidney Disease (CKD) or dehydration due to increased risk of side effects and worsened kidney function

Thromb Haemost 119:384396

However, their influence extends far beyond these primary benefits